The global Dermatology OTC Medications market size was valued at USD 13150 million in 2022 and is forecast to a readjusted size of USD 16350 million by 2029 with a CAGR of 3.2% during review period.
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over the counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
This report is a detailed and comprehensive analysis for global Dermatology OTC Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Dermatology OTC Medications market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dermatology OTC Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dermatology OTC Medications market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
External Use
Oral
Hospital
Drug Store
Other
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Increasing consumer demand for self-care and convenience drives growth in the OTC dermatology segment.
- Broad availability of OTC medications in both online and offline channels, improving market access.
Weaknesses:
- Regulatory challenges and safety concerns related to unapproved ingredients in some OTC dermatology products.
- Lack of awareness and education among consumers about the appropriate use of OTC dermatology treatments.
Opportunities:
- Rising prevalence of skin disorders and conditions like acne, eczema, and psoriasis, boosting demand.
- Innovations in dermatological formulations and natural ingredients offer potential for new product development.
Threats:
- Intense competition from both established pharmaceutical companies and new entrants in the market.
- Regulatory and policy changes that could impose stricter guidelines on OTC dermatology products.
Political:
- Government regulations on OTC medication sales may influence market accessibility and growth.
- Potential policy changes around healthcare spending could impact consumers’ willingness to pay for OTC dermatology products.
Economic:
- Economic downturns could reduce disposable income, impacting sales of non-essential OTC products.
- Growing middle-class population in emerging markets presents opportunities for increased product adoption.
Social:
- Rising awareness of skin health and self-care encourages more consumers to seek OTC dermatology solutions.
- Increasing focus on natural and sustainable ingredients in skincare products aligns with consumer preferences.
Technological:
- Advancements in dermatology research and the development of personalized OTC treatments enhance market offerings.
- E-commerce and digital platforms enable wider distribution and marketing of OTC dermatology products.
Environmental:
- Growing preference for eco-friendly packaging and ingredients could influence product formulations and marketing strategies.
- Regulatory pressure for sustainability in the cosmetic and pharmaceutical industries may increase production costs.
Legal:
- Stricter regulations on OTC dermatology ingredients and labeling may require companies to adjust their products and marketing.
- Intellectual property laws around new formulations could lead to increased innovation but also heighten competition.
Suppliers:
- Manufacturers of active pharmaceutical ingredients (APIs) and excipients for OTC dermatology products.
- Suppliers of packaging materials and eco-friendly alternatives for sustainable product offerings.
Inputs:
- Raw materials, including active ingredients like salicylic acid, benzoyl peroxide, and natural extracts.
- Regulatory standards and guidelines for OTC product formulation, labeling, and marketing.
Process:
- Research and development of new dermatology formulations targeting skin conditions like acne, eczema, and psoriasis.
- Manufacturing, packaging, and distribution through retail and e-commerce channels.
Outputs:
- OTC dermatology products such as creams, gels, lotions, and acne treatments.
- Product innovations, including those with organic or dermatologically-tested ingredients.
Customers:
- End consumers seeking effective, over-the-counter skincare solutions.
- Retailers, e-commerce platforms, and dermatology clinics offering OTC treatment options to patients.
Threat of New Entrants:
- Low barriers to entry due to the availability of third-party manufacturing and online sales channels.
- High competition from established brands with significant market share and brand loyalty.
Bargaining Power of Suppliers:
- Limited number of suppliers for high-quality active ingredients, giving suppliers moderate bargaining power.
- Increasing demand for sustainable and organic ingredients could shift supplier leverage.
Bargaining Power of Buyers:
- Consumers have a wide range of dermatology OTC options, enhancing their bargaining power.
- Growing awareness and access to information give consumers more influence in purchasing decisions.
Threat of Substitutes:
- Availability of alternative treatments, such as prescription medications or natural remedies, poses a threat.
- The rise of telemedicine and virtual dermatology consultations may lead to increased substitution of OTC products.
Industry Rivalry:
- Intense competition from both established pharmaceutical brands and new entrants in the OTC dermatology space.
- Price sensitivity and promotional activities lead to a highly competitive market environment.
Raw Materials and Ingredients:
- Increasing demand for natural and organic ingredients in dermatology products, influencing sourcing strategies.
- Fluctuations in the cost and availability of active ingredients like salicylic acid, retinoids, and benzoyl peroxide.
Manufacturing and Production:
- Contract manufacturing and third-party production are common, providing flexibility and reducing capital investment for smaller brands.
- Technological advancements in production methods, such as improved formulation techniques, are enhancing product quality and efficacy.
Regulatory Compliance:
- Stringent regulations on the safety, efficacy, and labeling of OTC dermatology products increase production costs.
- Manufacturers must adapt to evolving global standards to ensure market access across different regions.
Supply Chain and Distribution:
- The rise of direct-to-consumer sales through e-commerce channels has transformed traditional distribution models.
- Increasing consumer preference for local and sustainable products impacts sourcing and logistics strategies.
Product Development and Innovation:
- Continuous innovation in dermatology formulations, including the use of advanced delivery systems and multifunctional products.
- The focus on incorporating natural and clinically proven ingredients in product development to cater to consumer demand for safer, effective solutions.
Branding and Marketing:
- Strong brand differentiation through marketing campaigns highlighting product efficacy, dermatological testing, and natural ingredients.
- Increased use of digital marketing and influencer collaborations to reach a broader, tech-savvy consumer base.
Retail and Distribution Channels:
- Growth of omnichannel retailing, where both physical stores and online platforms are integrated to reach more consumers.
- Partnerships with pharmacies, skincare clinics, and dermatology specialists to increase visibility and product trustworthiness.
Consumer Education and Awareness:
- Increasing emphasis on educating consumers about proper product usage and the benefits of OTC treatments over prescription options.
- Collaborations with healthcare professionals and online platforms to build trust and inform consumers about skin health and product benefits.
Consumer Behavior:
- Increasing preference for self-diagnosis and self-treatment, leading to higher demand for OTC dermatology products.
- Growing consumer interest in skincare regimens and preventive care, influencing OTC product adoption.
Sales and Distribution:
- The rise of e-commerce platforms enables consumers to easily access dermatology OTC products, often with tailored recommendations.
- Retail pharmacies and dermatology clinics continue to play a significant role in product distribution, with a focus on providing expert guidance.
Market Trends:
- Strong consumer focus on personalized skincare, which is leading to more targeted OTC products designed for specific skin types or conditions.
- A shift toward sustainable and ethical brands, driven by consumer preferences for environmentally friendly and cruelty-free products.
Competitive Landscape:
- Large pharmaceutical companies dominate the market, but niche brands offering innovative, natural, or specialty solutions are gaining traction.
- Aggressive pricing strategies and frequent promotions by established brands intensify competition in the OTC dermatology sector.
Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales, revenue and global market share of Dermatology OTC Medications from 2018 to 2023.
Chapter 3, the Dermatology OTC Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Dermatology OTC Medications market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dermatology OTC Medications.
Chapter 14 and 15, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Dermatology OTC Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dermatology OTC Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 External Use
1.3.3 Oral
1.4 Market Analysis by Application
1.4.1 Overview: Global Dermatology OTC Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Drug Store
1.4.4 Other
1.5 Global Dermatology OTC Medications Market Size & Forecast
1.5.1 Global Dermatology OTC Medications Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Dermatology OTC Medications Sales Quantity (2018-2029)
1.5.3 Global Dermatology OTC Medications Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Dermatology OTC Medications Product and Services
2.1.4 Bayer Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Dermatology OTC Medications Product and Services
2.2.4 GSK Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Dermatology OTC Medications Product and Services
2.3.4 Teva Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Dermatology OTC Medications Product and Services
2.4.4 Johnson & Johnson Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Dermatology OTC Medications Product and Services
2.5.4 Novartis Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Dermatology OTC Medications Product and Services
2.6.4 Mylan Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mylan Recent Developments/Updates
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Dermatology OTC Medications Product and Services
2.7.4 Sun Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sun Pharmaceutical Recent Developments/Updates
2.8 Aurobindo
2.8.1 Aurobindo Details
2.8.2 Aurobindo Major Business
2.8.3 Aurobindo Dermatology OTC Medications Product and Services
2.8.4 Aurobindo Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Aurobindo Recent Developments/Updates
2.9 Galderma
2.9.1 Galderma Details
2.9.2 Galderma Major Business
2.9.3 Galderma Dermatology OTC Medications Product and Services
2.9.4 Galderma Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Galderma Recent Developments/Updates
2.10 CR SANJIU
2.10.1 CR SANJIU Details
2.10.2 CR SANJIU Major Business
2.10.3 CR SANJIU Dermatology OTC Medications Product and Services
2.10.4 CR SANJIU Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CR SANJIU Recent Developments/Updates
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Dermatology OTC Medications Product and Services
2.11.4 Dr. Reddy's Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dr. Reddy's Recent Developments/Updates
2.12 Lupin
2.12.1 Lupin Details
2.12.2 Lupin Major Business
2.12.3 Lupin Dermatology OTC Medications Product and Services
2.12.4 Lupin Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lupin Recent Developments/Updates
2.13 Bausch Health
2.13.1 Bausch Health Details
2.13.2 Bausch Health Major Business
2.13.3 Bausch Health Dermatology OTC Medications Product and Services
2.13.4 Bausch Health Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bausch Health Recent Developments/Updates
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business
2.14.3 Cipla Dermatology OTC Medications Product and Services
2.14.4 Cipla Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Cipla Recent Developments/Updates
2.15 Qilu Pharmaceutical
2.15.1 Qilu Pharmaceutical Details
2.15.2 Qilu Pharmaceutical Major Business
2.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product and Services
2.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Qilu Pharmaceutical Recent Developments/Updates
2.16 Almirall
2.16.1 Almirall Details
2.16.2 Almirall Major Business
2.16.3 Almirall Dermatology OTC Medications Product and Services
2.16.4 Almirall Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Almirall Recent Developments/Updates
2.17 Lingrui
2.17.1 Lingrui Details
2.17.2 Lingrui Major Business
2.17.3 Lingrui Dermatology OTC Medications Product and Services
2.17.4 Lingrui Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Lingrui Recent Developments/Updates
3 Competitive Environment: Dermatology OTC Medications by Manufacturer
3.1 Global Dermatology OTC Medications Sales Quantity by Manufacturer (2018-2023)
3.2 Global Dermatology OTC Medications Revenue by Manufacturer (2018-2023)
3.3 Global Dermatology OTC Medications Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Dermatology OTC Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Dermatology OTC Medications Manufacturer Market Share in 2022
3.4.2 Top 6 Dermatology OTC Medications Manufacturer Market Share in 2022
3.5 Dermatology OTC Medications Market: Overall Company Footprint Analysis
3.5.1 Dermatology OTC Medications Market: Region Footprint
3.5.2 Dermatology OTC Medications Market: Company Product Type Footprint
3.5.3 Dermatology OTC Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dermatology OTC Medications Market Size by Region
4.1.1 Global Dermatology OTC Medications Sales Quantity by Region (2018-2029)
4.1.2 Global Dermatology OTC Medications Consumption Value by Region (2018-2029)
4.1.3 Global Dermatology OTC Medications Average Price by Region (2018-2029)
4.2 North America Dermatology OTC Medications Consumption Value (2018-2029)
4.3 Europe Dermatology OTC Medications Consumption Value (2018-2029)
4.4 Asia-Pacific Dermatology OTC Medications Consumption Value (2018-2029)
4.5 South America Dermatology OTC Medications Consumption Value (2018-2029)
4.6 Middle East and Africa Dermatology OTC Medications Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Dermatology OTC Medications Sales Quantity by Type (2018-2029)
5.2 Global Dermatology OTC Medications Consumption Value by Type (2018-2029)
5.3 Global Dermatology OTC Medications Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Dermatology OTC Medications Sales Quantity by Application (2018-2029)
6.2 Global Dermatology OTC Medications Consumption Value by Application (2018-2029)
6.3 Global Dermatology OTC Medications Average Price by Application (2018-2029)
7 North America
7.1 North America Dermatology OTC Medications Sales Quantity by Type (2018-2029)
7.2 North America Dermatology OTC Medications Sales Quantity by Application (2018-2029)
7.3 North America Dermatology OTC Medications Market Size by Country
7.3.1 North America Dermatology OTC Medications Sales Quantity by Country (2018-2029)
7.3.2 North America Dermatology OTC Medications Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Dermatology OTC Medications Sales Quantity by Type (2018-2029)
8.2 Europe Dermatology OTC Medications Sales Quantity by Application (2018-2029)
8.3 Europe Dermatology OTC Medications Market Size by Country
8.3.1 Europe Dermatology OTC Medications Sales Quantity by Country (2018-2029)
8.3.2 Europe Dermatology OTC Medications Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Dermatology OTC Medications Market Size by Region
9.3.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Dermatology OTC Medications Sales Quantity by Type (2018-2029)
10.2 South America Dermatology OTC Medications Sales Quantity by Application (2018-2029)
10.3 South America Dermatology OTC Medications Market Size by Country
10.3.1 South America Dermatology OTC Medications Sales Quantity by Country (2018-2029)
10.3.2 South America Dermatology OTC Medications Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Dermatology OTC Medications Market Size by Country
11.3.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Dermatology OTC Medications Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Dermatology OTC Medications Market Drivers
12.2 Dermatology OTC Medications Market Restraints
12.3 Dermatology OTC Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Dermatology OTC Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dermatology OTC Medications
13.3 Dermatology OTC Medications Production Process
13.4 Dermatology OTC Medications Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dermatology OTC Medications Typical Distributors
14.3 Dermatology OTC Medications Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Dermatology OTC Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dermatology OTC Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Dermatology OTC Medications Product and Services
Table 6. Bayer Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Dermatology OTC Medications Product and Services
Table 11. GSK Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Dermatology OTC Medications Product and Services
Table 16. Teva Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Dermatology OTC Medications Product and Services
Table 21. Johnson & Johnson Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Johnson & Johnson Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Dermatology OTC Medications Product and Services
Table 26. Novartis Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Mylan Basic Information, Manufacturing Base and Competitors
Table 29. Mylan Major Business
Table 30. Mylan Dermatology OTC Medications Product and Services
Table 31. Mylan Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mylan Recent Developments/Updates
Table 33. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Major Business
Table 35. Sun Pharmaceutical Dermatology OTC Medications Product and Services
Table 36. Sun Pharmaceutical Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sun Pharmaceutical Recent Developments/Updates
Table 38. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 39. Aurobindo Major Business
Table 40. Aurobindo Dermatology OTC Medications Product and Services
Table 41. Aurobindo Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Aurobindo Recent Developments/Updates
Table 43. Galderma Basic Information, Manufacturing Base and Competitors
Table 44. Galderma Major Business
Table 45. Galderma Dermatology OTC Medications Product and Services
Table 46. Galderma Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Galderma Recent Developments/Updates
Table 48. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 49. CR SANJIU Major Business
Table 50. CR SANJIU Dermatology OTC Medications Product and Services
Table 51. CR SANJIU Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CR SANJIU Recent Developments/Updates
Table 53. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 54. Dr. Reddy's Major Business
Table 55. Dr. Reddy's Dermatology OTC Medications Product and Services
Table 56. Dr. Reddy's Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Dr. Reddy's Recent Developments/Updates
Table 58. Lupin Basic Information, Manufacturing Base and Competitors
Table 59. Lupin Major Business
Table 60. Lupin Dermatology OTC Medications Product and Services
Table 61. Lupin Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lupin Recent Developments/Updates
Table 63. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 64. Bausch Health Major Business
Table 65. Bausch Health Dermatology OTC Medications Product and Services
Table 66. Bausch Health Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bausch Health Recent Developments/Updates
Table 68. Cipla Basic Information, Manufacturing Base and Competitors
Table 69. Cipla Major Business
Table 70. Cipla Dermatology OTC Medications Product and Services
Table 71. Cipla Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Cipla Recent Developments/Updates
Table 73. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Qilu Pharmaceutical Major Business
Table 75. Qilu Pharmaceutical Dermatology OTC Medications Product and Services
Table 76. Qilu Pharmaceutical Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Qilu Pharmaceutical Recent Developments/Updates
Table 78. Almirall Basic Information, Manufacturing Base and Competitors
Table 79. Almirall Major Business
Table 80. Almirall Dermatology OTC Medications Product and Services
Table 81. Almirall Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Almirall Recent Developments/Updates
Table 83. Lingrui Basic Information, Manufacturing Base and Competitors
Table 84. Lingrui Major Business
Table 85. Lingrui Dermatology OTC Medications Product and Services
Table 86. Lingrui Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Lingrui Recent Developments/Updates
Table 88. Global Dermatology OTC Medications Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 89. Global Dermatology OTC Medications Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Dermatology OTC Medications Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 91. Market Position of Manufacturers in Dermatology OTC Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Dermatology OTC Medications Production Site of Key Manufacturer
Table 93. Dermatology OTC Medications Market: Company Product Type Footprint
Table 94. Dermatology OTC Medications Market: Company Product Application Footprint
Table 95. Dermatology OTC Medications New Market Entrants and Barriers to Market Entry
Table 96. Dermatology OTC Medications Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
Table 98. Global Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
Table 99. Global Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Dermatology OTC Medications Average Price by Region (2018-2023) & (USD/Unit)
Table 102. Global Dermatology OTC Medications Average Price by Region (2024-2029) & (USD/Unit)
Table 103. Global Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 104. Global Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 105. Global Dermatology OTC Medications Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Dermatology OTC Medications Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Dermatology OTC Medications Average Price by Type (2018-2023) & (USD/Unit)
Table 108. Global Dermatology OTC Medications Average Price by Type (2024-2029) & (USD/Unit)
Table 109. Global Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 110. Global Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 111. Global Dermatology OTC Medications Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Dermatology OTC Medications Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Dermatology OTC Medications Average Price by Application (2018-2023) & (USD/Unit)
Table 114. Global Dermatology OTC Medications Average Price by Application (2024-2029) & (USD/Unit)
Table 115. North America Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 116. North America Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 117. North America Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 118. North America Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 119. North America Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
Table 120. North America Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
Table 121. North America Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 124. Europe Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 125. Europe Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 126. Europe Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 127. Europe Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
Table 128. Europe Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
Table 129. Europe Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 132. Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 133. Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 134. Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 135. Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
Table 136. Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
Table 137. Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 140. South America Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 141. South America Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 142. South America Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 143. South America Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
Table 144. South America Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
Table 145. South America Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
Table 148. Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
Table 149. Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
Table 150. Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
Table 151. Middle East & Africa Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
Table 152. Middle East & Africa Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
Table 153. Middle East & Africa Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Dermatology OTC Medications Raw Material
Table 156. Key Manufacturers of Dermatology OTC Medications Raw Materials
Table 157. Dermatology OTC Medications Typical Distributors
Table 158. Dermatology OTC Medications Typical Customers
List of Figures
Figure 1. Dermatology OTC Medications Picture
Figure 2. Global Dermatology OTC Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dermatology OTC Medications Consumption Value Market Share by Type in 2022
Figure 4. External Use Examples
Figure 5. Oral Examples
Figure 6. Global Dermatology OTC Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Dermatology OTC Medications Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Other Examples
Figure 11. Global Dermatology OTC Medications Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Dermatology OTC Medications Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Dermatology OTC Medications Sales Quantity (2018-2029) & (M Units)
Figure 14. Global Dermatology OTC Medications Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Dermatology OTC Medications Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Dermatology OTC Medications Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Dermatology OTC Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Dermatology OTC Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Dermatology OTC Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Dermatology OTC Medications Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Dermatology OTC Medications Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Dermatology OTC Medications Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Dermatology OTC Medications Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
Figure 53. China Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Dermatology OTC Medications Market Drivers
Figure 74. Dermatology OTC Medications Market Restraints
Figure 75. Dermatology OTC Medications Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Dermatology OTC Medications in 2022
Figure 78. Manufacturing Process Analysis of Dermatology OTC Medications
Figure 79. Dermatology OTC Medications Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
